Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study [NA]

View source ↗

Summary

This update notes the completion of a mechanistic clinical trial evaluating the Reprieve Cardiovascular System for acute decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Reprieve Cardiovascular System

Snippet

Sponsor: Reprieve Cardiovascular, Inc | Conditions: Heart Failure | NA | Status: COMPLETED